NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

A Rise in the Population of the Elderly to Breathe Life into the In-vitro Diagnostics Market Finds Frost & Sullivan - Government support critical to bolster the US$252 million market - DrugDiscovery.Frost.com
A Rise in the Population of the Elderly to Breathe Life into the In-vitro Diagnostics Market Finds Frost & Sullivan

 

NewswireTODAY - /newswire/ - Taipei, Taiwan, 2011/08/03 - Government support critical to bolster the US$252 million market - DrugDiscovery.Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

With the elderly population accounting for 11 per cent (2.46 million) of Taiwan's population and this number expected to increase to 21 per cent in 2025, Taiwan has emerged a hotbed of opportunities for healthcare services and subsequently, in-vitro diagnostics. The need for early diagnosis for the elderly and an expected rise in healthcare spending due to citizens' desire for a healthy lifestyle and high-quality healthcare facilities will help the market grow at a stable compound annual growth rate of 6.1 per cent from 2010 to 2017.

New analysis from Frost & Sullivan (drugdiscovery.frost.com), In-vitro Diagnostics Market Outlook in Taiwan, finds that the market earned revenues of US$252.0 million in 2010 and expects this to reach US$381.0 million in 2017.

End users' growing willingness to use advanced tests and products will drive manufacturers to constantly introduce novel tests. Biotech participants will also be buoyed by the continuous Government support to standardise medical device and initiatives to develop the country into a healthcare hub. For instance, the Government has implemented the 'The Taiwan Diamond Plan for Biotechnology Development' to encourage R&D, accumulate biotechnology venture capital (BVC) and aid start-up enterprises.

"The Government intends to spend Taiwan new dollar (TND) 1.27 billion during 2009-2014 in the biotechnology industry to encourage the growth of the social BVC from TND891 million in 2009 to TND1.78 billion in 2014," says Frost & Sullivan Industry Analyst Arun A.K. "Through this plan, it hopes to increase the value of the biotechnology industry from TND4.29 billion in 2009 to TND8.58 billion in 2014."

Despite such robust Government backing, the low clarity on the reimbursement coverage for molecular tests will impede the market's growth. Further, intellectual property (IP) issues and legal challenges deter foreign companies from setting up their R&D centres in Taiwan. Local companies also have reasons to feel disgruntled, as the success of their innovative tests depends on insurance coverage.

"Strategic collaborations between local and international companies to develop cost-effective tests and innovative products offset their challenges to a great extent," notes Arun. "The establishment of the Taiwan Food and Drug Administration (TFDA) to regulate standards will help local companies launch their products efficiently in the country."

The TFDA will also serve as a springboard for the global market, as the Government is hoping to establish regulations that will meet international standards.

If you are interested in more information on this study, please send an email to Donna Jeremiah, Corporate Communications, at djeremiah[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country.

In-vitro Diagnostics Market Outlook in Taiwan is part of the Clinical Diagnostics Growth Partnership Services program, which also includes research in the following markets: In-vitro Diagnostics (IVD) Market Outlook in Korea, In-vitro Diagnostics (IVD) Market Outlook in Australia, European Tissue Diagnostics Market and European Microarrays Market. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


A Rise in the Population of the Elderly to Breathe Life into the In-vitro Diagnostics Market Finds Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Donna Jeremiah / Jessie Loh 
+603-6204-5832 / +65 6890 0942 djeremiah[.]frost.com / jessie.loh[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

SCHOTT Pharma Launches Large Format Ready-to-Use Cartridges for On-body Devices
Nexans Invests in its Draveil Site to Double Production Capacity of Medical Cables
SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion
Tongue-operated AI-powered Device that Aims to Challenge Neuralink, Wins Red Dot 2024 Award
Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories
Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics
Cancer Treatment Using Rotating Gantry of the Toshiba Heavy Ion Therapy System Starts At Yonsei University Health System
Bruker's Canopy Biosciences Announces the Launch of CellScape™ Whole-Slide Imaging Chamber for Spatial Biology
iSono Health Applauded by Frost & Sullivan for Ensuring Patient Comfort and Safety Providing Quality Imaging & Diagnosis with its iSono Health ATUSA
Bruker Launches the New BEAM, a Dedicated Single-Point FT-NIR Spectrometer Designed for In-Process Control
Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery At SLAS2024
Yokogawa Introduces CellVoyager High-Content Analysis System CQ3000
Advantech Introduces Cutting-Edge Solutions to Address Diverse Imaging Needs in Operating Rooms - The AVAS-2 Series for 4K Streaming Excellence
Seno Medical Earns Frost & Sullivan’s 2023 United States Enabling Technology Leadership Award for Delivering a More Efficient Breast Cancer Diagnosis
Withings Announces BeamO The Revolutionary At-home Health Checkup

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Limelon Advertising, Co.





 
  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)